Viewing data from:

QUINIDINE GLUCONATE

ANDA

QUINIDINE GLUCONATE | A212589 | HIBROW HEALTHCARE PRIVATE LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$5.07

per ea

Lowest NADAC/Unit

$5.07

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
71930001612QUINIDINE GLUC ER 324 MG TAB	$5.07	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain1 active DMF8 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

BUCHLER GMBHQUINIDINE GLUCONATE

DMF 325272018

SOCIETE CHIMIQUE POINTET GIRARD SAInactiveQUINIDINE GLUCONATE

DMF 27231976

DSM MINERA BVInactiveQUINIDINE GLUCONATE USP XIX

DMF 32411978

ROCHE DIAGNOSTICS GMBHInactiveQUINIDINE GLUCONATE & SULFATE USP XIX (BULK) & BP 1973

DMF 33551978

ISLAND CHEMICAL CO INCInactiveQUINIDINE GLUCONATE

DMF 36971980

SCHERING AGInactiveQUINIDINE GLUCONATE

DMF 50621983

FOREST LABORATORIES INCInactiveQUINIDINE GLUCONATE 650 MG. C.R. TABLETS

DMF 59041985

LEIRAS PHARMACEUTICALSInactiveQUINIDINE GLUCONATE EXTENDED RELEASE GRANULES

DMF 72921988

PT SINKONA INDONESIA LESTARIInactiveQUINIDINE GLUCONATE

DMF 123341997

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 8, 2021	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 324MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Sep 17, 2021

No patent or exclusivity listings for this strength.